Document Page: First | Prev | Next | All | Image | This Release | Search
File: 123096_sep96_decls23_0035.txt
Subject: DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANCE
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS
Document Number: 1
Folder Seq #: 88
TUBERCULOSIS
2. Erythromycin: 0.5 to 1 gm Q6h IV followed by 500
mg Q6h PO, once response has occurred to complete I. communicability:
full 10 day course; or
3. Vancomycin: 1 gm Q12h IV; switch to PO eryth- A. Route:
romycin to complete 10 day course. 1. Inhalation of airborne droplet nuclei from pro-
ductive cough of tuberculous patients.
D. Impetigoz 2. Ingestion of Infected unpasteurized dairy pro-
1. Penicillin V 250 mg PO QID for 10 days; or, ducts.
2. Erythromycin 250 mg PO QID for 10 days.
B. Isolation: respiratory isolation indicated for pa-
tients with cough productive of bacteriologically
VII. Disposition: positive (culture or smear) sputum. Appropriate
antituberculous drug therapy generally renders sputum
A. Local hospitalization required for scarlet fever, non-infectious in 2 weeks. If sputum status is un-
. known, isolate patient until it is determined.
B. Mild pharyngitis or impetigo may be returned to duty. C, Prophylaxis:
1. Household contacts (barracks or tent mates) should
C. Evacuation should rarely, if ever, be required unless be screened with intradermal intermediate strength
rheumatic fever, glomerulonephritis or advanced infec- (5-TU) PPD.
tious complications develop. 2. PPD negative contacts: retest in 2 to 3 months.
3. PPD positive contacts:
viii. Prognosis: excellent if treated. Complications of a. Check chest X-ray to rule out active pul-
untreated disease will be associated with serious monary disease.
sequelae in some cases. Scarlet fever and erysipelas b. If chest X-ray shows evidence of pulmonary
may be fatal if not properly treated. tuberculosis, evaluate and treat for active
disease (see below).
TX@ Public health measures: C. If CXR is negative or normal, consider INH
prophylaxis as follows:
A. No specific measures warranted under most circumstan- I) INII 300 mg PO QD for 6 months.
ces. Investigation of outbreaks is mandatory; inter- II) INH prophylaxis should not be given to
vention with prophylactic antibiotics may be required. patients: who have had prior INH
therapy; those older than age 35 years
B. Good hygiene will minimize incidence of streptococcal who have not had a negative IPPD within
skin infections. two years of the current testing; those
patients with active liver disease; and
those patients who have had previous
adverse reactions to INH.
III) delay prophylactic INH chemotherapy in
pregnant women until after delivery.
iv) advise discontinuation of alcohol intake
while on INH.
d. In cases of exposure to known INti-resistant
tuberculosis and subsequent PPD conversion,
alternative regimens include;
I) INH, 300 mg PO QD, for 6 months.
II) rifampin, 600 mg (10 mg/kg) PO QD, for 6
months; alone.
III) rifampin, 600 mg (10 mg/kg) PO QD, plus
ethambutol, 15-25 mg/kg QD, for 6
months.
61
60
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 52 f:/Week-36/BX003203/DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS/diagnosis and treatment of diseases of importanc:12179609281524
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS
Folder Seq # = 88
Subject = DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANC
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996